Quality of Life Assessment After HSCT for Pediatric and Adults

  • Anna BarataEmail author
  • Heather Jim


Methodological advances in the HCT field have increased the population of survivors worldwide. However, HCT is associated with significant morbidity that impairs survivors’ recovery and adversely affects their QoL.


  1. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.CrossRefGoogle Scholar
  2. Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2006. J Clin Epidemiol. 2010;63:1179–94.CrossRefGoogle Scholar
  3. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–9.CrossRefGoogle Scholar
  4. Hinds PS, Nuss SL, Ruccione KS, et al. PROMIS pediatric measures in pediatric oncology: valid and clinically feasible indicators of patient-reported outcomes. Pediatr Blood Cancer. 2013;60:402–8.CrossRefGoogle Scholar
  5. Kurosawa S, Oshima K, Yamaguchi T, et al. Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2017;23:1749–58.CrossRefGoogle Scholar
  6. Landgraf JM, Abetz L, Ware JE. Child health questionnaire (CHQ): a user’s manual. Boston: Health Institute, New England Medical Center; 1996.Google Scholar
  7. McQuellon RP, Russell GB, Cella DF, et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant. 1997;19:357–68.CrossRefGoogle Scholar
  8. Parsons SK, Shih MC, Mayer DK, Barlow SE, Supran SE, Levy SL, Greenield S, Kaplan SH. Preliminary psychometric evaluation of the Child Health Ratings Inventory (CHRIs) and Disease-Specific Impairment Inventory-Hematopoietic Stem Cell Transplantation (DSII-HSCT) in parents and children. Qual Life Res. 2005;14(86):1613–25.CrossRefGoogle Scholar
  9. Phipps S, Hinds PS, Channell S, et al. Measurement of behavioral, affective, and somatic responses to pediatric bone marrow transplantation: development of the BASES scale. J Pediat Oncol Nurs. 1994;11:109–17; discussion 118-119.CrossRefGoogle Scholar
  10. Pidala J, Anasetti C, Jim H. Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention. Br J Haematol. 2010;148:373–85.CrossRefGoogle Scholar
  11. van Reenen M, Jansen B. EQ-5D-5L user guide. Basic information on how to use the EQ-5D-5L instrument [Internet]. 2015 [cited 2018 Jan 24]. Accessed 12 Feb 2018.
  12. Russell KMW, Hudson M, Long A, et al. Assessment of health-related quality of life in children with cancer: consistency and agreement between parent and child reports. Cancer. 2006;106:2267–74.CrossRefGoogle Scholar
  13. Shaw BE, Lee SJ, Horowitz MM, et al. Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN. Bone Marrow Transplant. 2016;51:1173–9.CrossRefGoogle Scholar
  14. US Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. US Department of Health and Human Services. Food and Drug Administration. 2009. Accessed 12 Feb 2018.
  15. Varni JW, Burwinkle TM, Katz ER, et al. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory generic core scales, multidimensional fatigue scale, and cancer module. Cancer. 2002;94:2090–106.CrossRefGoogle Scholar
  16. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800–12.CrossRefGoogle Scholar
  17. Ware JE, Kosinski M, Keller S. SF-36 physical and mental health summary scales: a user’s manual. Boston: Health Institute; 1994.Google Scholar
  18. Young TA, Mukuria C, Rowen D, et al. Mapping functions in health-related quality of life: mapping from two cancer-specific health-related quality-of-life instruments to EQ-5D-3L. Med Decis Mak. 2015;35:912–26.CrossRefGoogle Scholar

Copyright information

© EBMT and the Author(s) 2019

Open Access This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The images or other third party material in this chapter are included in the chapter’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Authors and Affiliations

  1. 1.Department of HematologyHospital de la Santa Creu i Sant Pau, Universitat Autònoma de BarcelonaBarcelonaSpain
  2. 2.José Carreras Leukemia Research InstituteBarcelonaSpain
  3. 3.Department of Health Outcomes and BehaviorMoffitt Cancer CenterTampaUSA

Personalised recommendations